Massive pulmonary embolism: a remarkable case and review of treatment

Cooper, Joshua M; Beckman, Joshua A
August 2002
Vascular Medicine;2002, Vol. 7 Issue 3, p181
Academic Journal
Although the clinical syndrome following pulmonary embolism (PE) may be subtle, in the case of massive PE the severity of the clinical presentation typically makes the picture more obvious. If more than two lobar pulmonary arteries become obstructed, the hemodynamic and respiratory consequences are severe, and may be life threatening. We present an unusual case where a patient experienced transient hemodynamic collapse during valsalva, and a massive saddle pulmonary embolus was discovered incidentally. Current treatment options for massive PE are then discussed.


Related Articles

  • Akut Masif Pulmoner Embolide Lokal Intravask�ler Trombolitik Uygulama: Olgu Sunumu. Akkoyunlu, Muhammet Emin; Altin, Remzi; Kart, Levent; Tor, Meltem; Altunkaya, S�leyman Aykut; Atalay, Figen; �rnek, T. // Akciger Arsivi/Archives of Lung;Dec2007, Vol. 8 Issue 4, p137 

    Pulmonary embolism is a common disease with high mortality and morbidity rates. Incidence of the disease is increasing associated with the development in the diagnostic methods. Anticoagulation is the standard treatment for pulmonary embolism. However, thrombolytic treatment is a significant...

  • Salvage intraosseous thrombolysis and extracorporeal membrane oxygenation for massive pulmonary embolism. Northey, Luke Cameron; Shiraev, Timothy; Omari, Abdullah // Journal of Emergencies, Trauma & Shock;Jan-Mar2015, Vol. 8 Issue 1, p55 

    Intraosseous access is an alternative route of pharmacotherapy during cardiopulmonary resuscitation. Extracorporeal membrane oxygenation (ECMO) provides cardiac and respiratory support when conventional therapies fail. This case reports the use of intraosseous thrombolysis and ECMO in a patient...

  • Pulmonary embolism in a developing country: A review. Wani, Imtiaz; Gul, Imran; Bhat, Zubair; Nazir, Mir // Internet Journal of Third World Medicine;2009, Vol. 8 Issue 2, p7 

    Mortality associated with pulmonary embolism can be reduced significantly by timely diagnosis, leading to early and prompt treatment. History and physical examination findings are often nonspecific in patients with pulmonary embolism, but in developing country, there are most reliable in...

  • Certain Thrombolysis Patients Have a High Mortality Risk.  // Pulmonary Reviews;Dec2008, Vol. 13 Issue 12, p20 

    The article discusses research being done on thrombolytic therapy. It references a study by Said A. Ibrahim et al published in the November 10, 2008 issue of "Archives of Internal Medicine." Findings show that thrombolytic therapy appears to increase in-hospital and 30-day mortality risk in...

  • Thrombolytic Therapy for Pulmonary Embolism. Beckman, Joshua A. // JAMA: Journal of the American Medical Association;6/18/2014, Vol. 311 Issue 23, p2385 

    The article discusses the thrombolysis for pulmonary embolism (PE) which accounted for about 30,000 deaths in the U.S. each year. Topics discussed include the treatment for PE including the need to balance the benefits of anticoagulation with the risk of bleeding, anticoagulation as standard...

  • Massive Pulmonary Embolus. Tuna, Ishik C.; Harrison, Michael R.; Curtis, David B.; Humbert Jr., Vernon H.; Webster, Stevan A. // Texas Heart Institute Journal;2002, Vol. 29 Issue 2, p144 

    Presents the case of a middle-aged man with a saddle embolus of the pulmonary artery. Medical history of the patient; Diagnosis and treatment; Implications for the management of pulmonary emboli.

  • Thrombolysis and pulmonary embolism. Rowbury, Gemma // British Journal of Cardiac Nursing;Feb2013, Vol. 8 Issue 2, p80 

    Acute pulmonary embolism is a condition that is associated with serious morbidity and mortality. Thrombolysis is a therapeutic option advocated by national guidelines for patients with haemodynamic compromise. However, this treatment is the subject of debate and there are a number of...

  • Letters to the Editor. Mofredj, Ali; Baraka, Daoud; Beldjoudi, Brahim; Almoosa, Khalid // American Family Physician;8/15/2002, Vol. 66 Issue 4, p560 

    Comments on a study which examined the effectiveness of thrombolytic therapy in the treatment for pulmonary embolism. Background on thrombolytic therapy; Results of related clinical trials; Controversy surrounding the treatment.

  • Long-term benefit of thrombolytic therapy in patients with pulmonary embolism. Sharma, G.V.R.K.; Folland, E.D.; McIntyre, K.M.; Sasahara, A.A. // Vascular Medicine;2000, Vol. 5 Issue 2, p91 

    A total of 23 of the 40 patients who had angiographically proven pulmonary embolism and who had initially been randomized to an IV infusion of heparin ( n= 11) or a thrombolytic agent (urokinase or streptokinase, n = 12) were restudied after a mean follow-up of 7.4 years to measure the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics